Re-thinking the treatment of depression: have we been misinformed about antidepressants? A webinar discussion with Irving Kirsch, Ph.D. and Michael D. Yapko, Ph.D.

Sources and suggested readings

• Bisby, M. A., Scott, A. J., & Fisher, A., Gandy, M., Hathway, T., Heriseanu, A. I., Karin, E., Cross, S., Staples, L., Titov, N., & Dear, B. F. (2022). The timing and magnitude of symptom improvements during an Internet-delivered transdiagnostic treatment program for anxiety and depression. Journal of Consulting and Clinical Psychology. Advance online publication. https://doi.org/10.1037/ccp0000761
   Web of Science ®Google Scholar
• Cenat, J., Farahi, S., Dalexis, R. D., Darius, W. P., Bekarkhanechi, F. M., Poisson, H., Broussard, C., Ukwu, G., Auguste, E., Nguyen, D. D., Sehabi, G., Furyk, S. E., Gedeon, A. P., Onesi, O., El Aouame, A. M., Khodabocus, S. N., Shah, M. S., & Labelle, P. R. (2022, October 15). The global evolution of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis of longitudinal studies. Journal of Affective Disorders, 315, 70–95. https://doi.org/10.1016/j.jad.2022.07.011
   PubMed Web of Science ®Google Scholar
• Hoge, E. J., Bui, E., Mete, M., Dutton, M. A., Baker, A. W., & Simon, N. M. (2022, November 9). Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: A randomized clinical trial. JAMA Psychiatry. 80(1), 13. https://doi.org/10.1001/jamapsychiatry.2022.3679
   Web of Science ®Google Scholar
• Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., & Brown, W. A. (2012, July). A systematic review of comparative efficacy of treatments and controls for depression. PLOS ONE, 7(7), e41778. https://doi.org/10.1371/journal.pone.0041778
   PubMed Web of Science ®Google Scholar
• Kirsch, I. (2016). The placebo effect in the treatment of depression. Verhaltenstherapie, 26(1), 55–61. https://doi.org/10.1159/000443542
   Web of Science ®Google Scholar
• Kirsch, I. (2019). Placebo effect in the treatment of depression and anxiety. Frontiers in Psychiatry, 10, 407. https://doi.org/10.3389/fpsyt.2019.00407
   PubMed Web of Science ®Google Scholar
• Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLOS Medicine, 5(2), e45. https://doi.org/10.1371/journal.pmed.0050045
   PubMed Web of Science ®Google Scholar
• Kirsch, I., Huedo-Medina, T. B., Pigott, H. E., & Johnson, B. T. (2018, September 17). Do outcomes of clinical trials resemble those of “real world” patients? A reanalysis of the STAR*D antidepressant data set. Psychology of Consciousness: Theory, Research, & Practice. Advance online publication. https://doi.org/10.1037/cns0000164
   Google Scholar
• Kirsch, I., & Low, C. (2013). Suggestion in the treatment of depression. American Journal of Clinical Hypnosis, 55(3), 221–229. https://doi.org/10.1080/00029157.2012.738613
   PubMed Web of Science ®Google Scholar
• Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002). The emperor’s new drugs: An analysis of antidepressant medication data submitted to the US food and drug administration. Prevention & Treatment, 5(1), 23a. https://doi.org/10.1037/1522-3736.5.1.523a
   Google Scholar
• Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), 2a. https://doi.org/10.1037/1522-3736.1.1.12a
   Google Scholar
• Locher, C., Koechlin, H., Zion, S., Werner, C., Pine, D. S., Kirsch, I., Kessler, R. C., & Kossowsky, J. (2017). Efficacy and safety of SSRIs, SNRIs, and placebo in common psychiatric disorders: A comprehensive meta-analysis in children and adolescents. JAMA Psychiatry, 74(10), 1011–1020. https://doi.org/10.1001/jamapsychiatry.2017.2432
   PubMed Web of Science ®Google Scholar
• Locher, C., Kossowsky, J., Gaab, J., Kirsch, I., Bain, P., & Krummenacher, P. (2015). Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis. Journal of Affective Disorders, 181, 50–60. https://doi.org/10.1016/j.jad.2015.03.062
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., Cooper, R., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022, July). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243–3256. https://doi.org/10.1038/s41380-022-01661-0
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., & Kirsch, I. (2015). Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemporary Clinical Trials, 43, 60–62. https://doi.org/10.1016/j.cct.2015.05.005
   PubMed Web of Science ®Google Scholar
• Rushton, J., Clark, S., & Freed, G. (2000). Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics, 105(6), e82. https://doi.org/10.1542/peds.105.6.e82
   PubMed Web of Science ®Google Scholar
• Sachs, G. S., Yeung, P. P., Rekeda, L., Khan, A., Adams, J. L., & Fava, M. (2023). Adjunctive cariprazine for the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled phase 3 study. American Journal of Psychiatry, 180(3), 241–251. https://doi.org/10.1176/appi.ajp.20220504
   PubMed Web of Science ®Google Scholar
• Sapkota, R. P., Peynenburg, V., Dear, B. F., Titov, N., & Hadjistavropoulos, H. D. (2022). Engagement with homework in an internet-delivered therapy predicts reduced anxiety and depression symptoms: A latent growth curve analysis. Journal of Consulting and Clinical Psychology. Advance online publication. https://doi.org/10.1037/ccp0000775
   PubMed Web of Science ®Google Scholar
• Singh, B., Olds, T., Curtis, R., Dumuid, D., Virgara, R., Watson, A., Szeto, K., O’Connor, E., Ferguson, T., Eglitis, E., Miatke, A., Simpson, C. E., & Maher, C. (2023, February). Effectiveness of physical activity interventions for improving depression, anxiety, and distress. British Journal of Sports Medicine, 57(18), 1203–1209. https://doi.org/10.1136/bjsports-2022-106195
   PubMed Web of Science ®Google Scholar
• Stone, M., Yaseen, Z., Miller, B., Richardville, K., Kalaria, S., & Kirsch, I. (2022). Response to acute monotherapy for major depressive disorder in randomized, placebo-controlled trials submitted to the US food and drug administration: Individual participant data analysis. British Medical Journal, 378, e067606. https://doi.org/10.1136/bmj-2021-067606
   PubMedGoogle Scholar
• Sugarman, M. A., Loree, A. M., Baltes, B. B., Grekin, E. R., & Kirsch, I. (2014). The efficacy of paroxetine and placebo in treating anxiety and depression: A meta-analysis of change on the Hamilton rating scales. PLOS ONE, 9(8), e106337. https://doi.org/10.1371/journal.pone.0106337
   PubMed Web of Science ®Google Scholar
• Yapko, M. (2009). Depression is contagious: How the most common mood disorder is spreading around the world and how to stop it. Free Press.
   Google Scholar
• Yapko, M. (2019). Trancework: An introduction to the practice of clinical hypnosis (5th ed.). Routledge.
   Google Scholar